BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 30261192)

  • 1. High-grade precursor lesions can be used as surrogate markers to identify the epicenter of periampullary carcinomas.
    Jeong BK; Sung YN; Kim SJ; An S; Park H; Hwang HS; Kang HJ; Lee JH; Song KB; Kim KP; Hwang DW; Lee SS; Kim SC; Hong SM
    Hum Pathol; 2019 Feb; 84():92-104. PubMed ID: 30261192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Histopathologic Phenotype of Periampullary Adenocarcinomas With Survival.
    Williams JL; Chan CK; Toste PA; Elliott IA; Vasquez CR; Sunjaya DB; Swanson EA; Koo J; Hines OJ; Reber HA; Dawson DW; Donahue TR
    JAMA Surg; 2017 Jan; 152(1):82-88. PubMed ID: 27732711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution and pathological features of pancreatic, ampullary, biliary and duodenal cancers resected with pancreaticoduodenectomy.
    Chandrasegaram MD; Chiam SC; Chen JW; Khalid A; Mittinty ML; Neo EL; Tan CP; Dolan PM; Brooke-Smith ME; Kanhere H; Worthley CS
    World J Surg Oncol; 2015 Feb; 13():85. PubMed ID: 25890023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential diagnosis of periampullary carcinomas at MR imaging.
    Kim JH; Kim MJ; Chung JJ; Lee WJ; Yoo HS; Lee JT
    Radiographics; 2002; 22(6):1335-52. PubMed ID: 12432106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Periampullary carcinoma or tumor of the ampulla of Vater?].
    Vasilescu C; Herlea V; Stoicescu M
    Chirurgia (Bucur); 2000; 95(5):401-6. PubMed ID: 14870549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal-type and pancreatobiliary-type adenocarcinomas: how does ampullary carcinoma differ from other periampullary malignancies?
    Westgaard A; Pomianowska E; Clausen OP; Gladhaug IP
    Ann Surg Oncol; 2013 Feb; 20(2):430-9. PubMed ID: 22956064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological Stratification and Long-term Follow-up of Patients with Periampullary Carcinomas.
    Schmuck RB; Brokat C; Andreou A; Felsenstein M; Klein F; Sinn B; Pratschke J; Bahra M
    Anticancer Res; 2018 Sep; 38(9):5379-5386. PubMed ID: 30194192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-ampullary papillary-tubular neoplasm (IAPN): characterization of tumoral intraepithelial neoplasia occurring within the ampulla: a clinicopathologic analysis of 82 cases.
    Ohike N; Kim GE; Tajiri T; Krasinskas A; Basturk O; Coban I; Bandyopadhyay S; Morohoshi T; Goodman M; Kooby DA; Sarmiento JM; Adsay NV
    Am J Surg Pathol; 2010 Dec; 34(12):1731-48. PubMed ID: 21084962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrapancreatic distal common bile duct carcinoma: Analysis, staging considerations, and comparison with pancreatic ductal and ampullary adenocarcinomas.
    Gonzalez RS; Bagci P; Basturk O; Reid MD; Balci S; Knight JH; Kong SY; Memis B; Jang KT; Ohike N; Tajiri T; Bandyopadhyay S; Krasinskas AM; Kim GE; Cheng JD; Adsay NV
    Mod Pathol; 2016 Nov; 29(11):1358-1369. PubMed ID: 27469329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour origin, diagnostic accuracy and histopathological evaluation in patients with periampullary cancer: nationwide cohort study.
    Byrling J; Ghazi S; Andersson B
    BJS Open; 2023 Sep; 7(5):. PubMed ID: 37864577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Periampullary adenocarcinoma: analysis of 5-year survivors.
    Yeo CJ; Sohn TA; Cameron JL; Hruban RH; Lillemoe KD; Pitt HA
    Ann Surg; 1998 Jun; 227(6):821-31. PubMed ID: 9637545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal-type of differentiation predicts favourable overall survival: confirmatory clinicopathological analysis of 198 periampullary adenocarcinomas of pancreatic, biliary, ampullary and duodenal origin.
    Bronsert P; Kohler I; Werner M; Makowiec F; Kuesters S; Hoeppner J; Hopt UT; Keck T; Bausch D; Wellner UF
    BMC Cancer; 2013 Sep; 13():428. PubMed ID: 24053229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [CT-guided percutaneous fine needle aspiration cytodiagnosis of pancreatic and periampullary tumors].
    Jia ZG; Pan RQ; Liu DH
    Zhonghua Zhong Liu Za Zhi; 1987 Mar; 9(2):124-6. PubMed ID: 3652914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histopathologic Analysis of Pancreaticoduodenectomy Specimen.
    Dhakhwa R; Kafle N
    JNMA J Nepal Med Assoc; 2016; 55(204):79-85. PubMed ID: 28029673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 15-year experience with surgical treatment of duodenal carcinoma: a comparison of periampullary and extra-ampullary duodenal carcinomas.
    Onkendi EO; Boostrom SY; Sarr MG; Farnell MB; Nagorney DM; Donohue JH; Kendrick ML; Reid-Lombardo KM; Harmsen WS; Que FG
    J Gastrointest Surg; 2012 Apr; 16(4):682-91. PubMed ID: 22350721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreaticobiliary duct changes of periampullary carcinomas: quantitative analysis at MR imaging.
    Wu DS; Chen WX; Wang XD; Acharya R; Jiang XH
    Eur J Radiol; 2012 Sep; 81(9):2112-7. PubMed ID: 21908124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of p16 protein and cyclin D1 in periampullary carcinomas.
    Tuncer E; Türk NS; Arici S; Düzcan SE; Demirkan NC
    Turk Patoloji Derg; 2011 Jan; 27(1):17-22. PubMed ID: 21469422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controversies in the diagnosis and treatment of periampullary tumours.
    Skórzewska M; Kurzawa P; Ciszewski T; Pelc Z; Polkowski WP
    Surg Oncol; 2022 Sep; 44():101853. PubMed ID: 36152420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinguishing pancreatic carcinoma from other periampullary carcinomas by analysis of mutations in the Kirsten-ras oncogene.
    Motojima K; Tsunoda T; Kanematsu T; Nagata Y; Urano T; Shiku H
    Ann Surg; 1991 Dec; 214(6):657-62. PubMed ID: 1741644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recognition and pathological features of periampullary region adenocarcinoma with an indeterminable origin.
    Komine R; Kojima M; Ishi G; Kudo M; Sugimoto M; Kobayashi S; Takahashi S; Konishi M; Kobayashi T; Akimoto T; Murakami A; Sasaki M; Tanaka M; Matsuzaki A; Ohike N; Uchida K; Sugiyama T; Hirabayashi K; Tajiri T; Ishida K; Kai K; Omori Y; Notohara K; Yamaguchi H; Matsuda Y; Naito Y; Fukumura Y; Hamada Y; Mihara Y; Masugi Y; Gotohda N; Harada K; Fukushima N; Furukawa T
    Cancer Med; 2021 Jun; 10(11):3499-3510. PubMed ID: 34008914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.